Effects of isoflavone on the learning and memory of women in menopause: a double-blind placebo-controlled study

Effects of isoflavone on the learning and memory of women in menopause: a double-blind placebo-controlled study

Autor Santos-Galduróz, Ruth Ferreira Google Scholar
Galduróz, José Carlos Fernandes Autor UNIFESP Google Scholar
Facco, R.L. Google Scholar
Hachul, Helena Autor UNIFESP Google Scholar
Tufik, Sergio Autor UNIFESP Google Scholar
Instituição Universidade Estadual Paulista (UNESP)
Universidade Federal do ABC Centro de Matemática, Computação e Cognição
Universidade Federal de São Paulo (UNIFESP)
Independent researcher in private practice Departamento de Psicobiologia
Resumo Hormone decline is common to all women during aging and, associated with other factors, leads to cognitive impairment. Its replacement enhances cognitive performance, but not all women present a clinical and family or personal history that justifies its use, mainly women with a history of cancer. The aim of this study was to determine whether a daily oral dose of 80 mg of isoflavone extract for 4 months can produce benefits in women with low hormone levels, contributing to improvement in cognitive aspects. The sample comprised 50- to 65-year-old women whose menstruation had ceased at least 1 year before and who had not undergone hormone replacement. The volunteers were allocated to two groups of 19 individuals each, i.e., isoflavone and placebo. There was a weak correlation between menopause duration and low performance in the capacity to manipulate information (central executive). We observed an increase in the capacity to integrate information in the group treated with isoflavone, but no improvement in the capacity to form new memories. We did not observe differences between groups in terms of signs and symptoms suggestive of depression according to the Geriatric Depression Scale. Our results point to a possible beneficial effect of isoflavone on some abilities of the central executive. These effects could also contribute to minimizing the impact of memory impairment. Further research based on controlled clinical trials is necessary to reach consistent conclusions.
Assunto Isoflavone
Cognitive disorders
Information integration
Idioma Inglês
Financiador Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Associação Fundo de Incentivo à Pesquisa (AFIP)
Data 2010-11-01
Publicado em Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 43, n. 11, p. 1123-1126, 2010.
ISSN 0100-879X (Sherpa/Romeo, fator de impacto)
Editor Associação Brasileira de Divulgação Científica
Extensão 1123-1126
Fonte http://dx.doi.org/10.1590/S0100-879X2010007500104
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000284591800016
SciELO S0100-879X2010001100016 (estatísticas na SciELO)
URI http://repositorio.unifesp.br/handle/11600/6006

Mostrar registro completo

Arquivos deste item

Nome: S0100-879X2010001100016.pdf
Tamanho: 356.5Kb
Formato: PDF

Este item aparece na(s) seguinte(s) coleção(s)